nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Pilocarpine—glaucoma	0.111	0.236	CbGbCtD
Conivaptan—CYP3A4—Brinzolamide—glaucoma	0.0874	0.185	CbGbCtD
Conivaptan—CYP3A4—Dorzolamide—glaucoma	0.0844	0.178	CbGbCtD
Conivaptan—CYP3A4—Methazolamide—glaucoma	0.0752	0.159	CbGbCtD
Conivaptan—CYP3A4—Acetazolamide—glaucoma	0.0601	0.127	CbGbCtD
Conivaptan—CYP3A4—Clonidine—glaucoma	0.0544	0.115	CbGbCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—OPN4—glaucoma	0.00214	0.0378	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—PTGFR—glaucoma	0.00193	0.034	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00191	0.0338	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00181	0.0319	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00179	0.0317	CbGpPWpGaD
Conivaptan—Pain—Carbachol—glaucoma	0.00178	0.00378	CcSEcCtD
Conivaptan—Haematuria—Pilocarpine—glaucoma	0.00176	0.00374	CcSEcCtD
Conivaptan—Feeling abnormal—Diclofenamide—glaucoma	0.00176	0.00373	CcSEcCtD
Conivaptan—Pain—Levobunolol—glaucoma	0.00175	0.00372	CcSEcCtD
Conivaptan—Thirst—Betaxolol—glaucoma	0.00175	0.00372	CcSEcCtD
Conivaptan—Orthostatic hypotension—Clonidine—glaucoma	0.00175	0.00371	CcSEcCtD
Conivaptan—Urinary tract disorder—Travoprost—glaucoma	0.00172	0.00366	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00172	0.0304	CbGpPWpGaD
Conivaptan—Urethral disorder—Travoprost—glaucoma	0.00171	0.00364	CcSEcCtD
Conivaptan—Hypoglycaemia—Betaxolol—glaucoma	0.00171	0.00362	CcSEcCtD
Conivaptan—Cardiac failure—Betaxolol—glaucoma	0.00171	0.00362	CcSEcCtD
Conivaptan—Cardiac disorder—Brimonidine—glaucoma	0.0017	0.00362	CcSEcCtD
Conivaptan—Urinary tract disorder—Brinzolamide—glaucoma	0.0017	0.00362	CcSEcCtD
Conivaptan—Oedema peripheral—Brinzolamide—glaucoma	0.0017	0.00361	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methazolamide—glaucoma	0.00169	0.0036	CcSEcCtD
Conivaptan—Urethral disorder—Brinzolamide—glaucoma	0.00169	0.00359	CcSEcCtD
Conivaptan—Feeling abnormal—Levobunolol—glaucoma	0.00169	0.00359	CcSEcCtD
Conivaptan—Body temperature increased—Diclofenamide—glaucoma	0.00169	0.00358	CcSEcCtD
Conivaptan—Angiopathy—Brimonidine—glaucoma	0.00167	0.00354	CcSEcCtD
Conivaptan—Mediastinal disorder—Brimonidine—glaucoma	0.00165	0.00351	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00165	0.0292	CbGpPWpGaD
Conivaptan—Body temperature increased—Carbachol—glaucoma	0.00164	0.00349	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00164	0.029	CbGpPWpGaD
Conivaptan—Oedema peripheral—Pilocarpine—glaucoma	0.00163	0.00347	CcSEcCtD
Conivaptan—Pain—Latanoprost—glaucoma	0.00162	0.00345	CcSEcCtD
Conivaptan—Cardiac disorder—Travoprost—glaucoma	0.00162	0.00344	CcSEcCtD
Conivaptan—Feeling abnormal—Methazolamide—glaucoma	0.00162	0.00344	CcSEcCtD
Conivaptan—Mental disorder—Brimonidine—glaucoma	0.00161	0.00342	CcSEcCtD
Conivaptan—Cardiac disorder—Brinzolamide—glaucoma	0.0016	0.0034	CcSEcCtD
Conivaptan—Erythema—Brimonidine—glaucoma	0.0016	0.00339	CcSEcCtD
Conivaptan—Angiopathy—Travoprost—glaucoma	0.00158	0.00336	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00157	0.00334	CcSEcCtD
Conivaptan—Mediastinal disorder—Travoprost—glaucoma	0.00157	0.00334	CcSEcCtD
Conivaptan—Angiopathy—Brinzolamide—glaucoma	0.00156	0.00332	CcSEcCtD
Conivaptan—Hypertension—Bimatoprost—glaucoma	0.00156	0.00331	CcSEcCtD
Conivaptan—Mediastinal disorder—Brinzolamide—glaucoma	0.00155	0.0033	CcSEcCtD
Conivaptan—Body temperature increased—Methazolamide—glaucoma	0.00155	0.0033	CcSEcCtD
Conivaptan—Dry mouth—Apraclonidine—glaucoma	0.00155	0.00329	CcSEcCtD
Conivaptan—Mental disorder—Travoprost—glaucoma	0.00153	0.00325	CcSEcCtD
Conivaptan—Pollakiuria—Clonidine—glaucoma	0.00153	0.00324	CcSEcCtD
Conivaptan—Erythema—Dorzolamide—glaucoma	0.00153	0.00324	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00153	0.00324	CcSEcCtD
Conivaptan—Erythema—Travoprost—glaucoma	0.00152	0.00323	CcSEcCtD
Conivaptan—Hypokalaemia—Betaxolol—glaucoma	0.00152	0.00322	CcSEcCtD
Conivaptan—Mental disorder—Brinzolamide—glaucoma	0.00151	0.00321	CcSEcCtD
Conivaptan—Infection—Apraclonidine—glaucoma	0.00151	0.00321	CcSEcCtD
Conivaptan—Pruritus—Diclofenamide—glaucoma	0.00151	0.0032	CcSEcCtD
Conivaptan—Dry mouth—Bimatoprost—glaucoma	0.0015	0.00319	CcSEcCtD
Conivaptan—Malnutrition—Brinzolamide—glaucoma	0.0015	0.00319	CcSEcCtD
Conivaptan—Erythema—Brinzolamide—glaucoma	0.0015	0.00319	CcSEcCtD
Conivaptan—Nervous system disorder—Apraclonidine—glaucoma	0.00149	0.00316	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00149	0.0263	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00148	0.0261	CbGpPWpGaD
Conivaptan—Skin disorder—Apraclonidine—glaucoma	0.00148	0.00313	CcSEcCtD
Conivaptan—Headache—Metipranolol—glaucoma	0.00147	0.00312	CcSEcCtD
Conivaptan—Infection—Bimatoprost—glaucoma	0.00146	0.00311	CcSEcCtD
Conivaptan—Pruritus—Levobunolol—glaucoma	0.00145	0.00308	CcSEcCtD
Conivaptan—Nervous system disorder—Bimatoprost—glaucoma	0.00144	0.00307	CcSEcCtD
Conivaptan—Urinary tract infection—Clonidine—glaucoma	0.00143	0.00304	CcSEcCtD
Conivaptan—Skin disorder—Bimatoprost—glaucoma	0.00143	0.00304	CcSEcCtD
Conivaptan—Diarrhoea—Carbachol—glaucoma	0.00142	0.00302	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00142	0.025	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00141	0.0248	CbGpPWpGaD
Conivaptan—Diarrhoea—Levobunolol—glaucoma	0.0014	0.00298	CcSEcCtD
Conivaptan—Hypoglycaemia—Timolol—glaucoma	0.00139	0.00296	CcSEcCtD
Conivaptan—Cardiac failure—Timolol—glaucoma	0.00139	0.00296	CcSEcCtD
Conivaptan—Nausea—Metipranolol—glaucoma	0.00139	0.00295	CcSEcCtD
Conivaptan—Hypertension—Brimonidine—glaucoma	0.00138	0.00293	CcSEcCtD
Conivaptan—Insomnia—Apraclonidine—glaucoma	0.00137	0.00292	CcSEcCtD
Conivaptan—Confusional state—Acetazolamide—glaucoma	0.00137	0.00291	CcSEcCtD
Conivaptan—Headache—Carteolol—glaucoma	0.00136	0.00289	CcSEcCtD
Conivaptan—Vomiting—Diclofenamide—glaucoma	0.00136	0.00288	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00135	0.00287	CcSEcCtD
Conivaptan—Pruritus—Latanoprost—glaucoma	0.00134	0.00286	CcSEcCtD
Conivaptan—Diarrhoea—Methazolamide—glaucoma	0.00134	0.00285	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00134	0.0237	CbGpPWpGaD
Conivaptan—Headache—Diclofenamide—glaucoma	0.00134	0.00284	CcSEcCtD
Conivaptan—Insomnia—Bimatoprost—glaucoma	0.00133	0.00283	CcSEcCtD
Conivaptan—Dry mouth—Brimonidine—glaucoma	0.00133	0.00283	CcSEcCtD
Conivaptan—Vomiting—Carbachol—glaucoma	0.00132	0.00281	CcSEcCtD
Conivaptan—Hypertension—Dorzolamide—glaucoma	0.00132	0.0028	CcSEcCtD
Conivaptan—Hypertension—Travoprost—glaucoma	0.00131	0.00279	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00131	0.00279	CcSEcCtD
Conivaptan—Headache—Carbachol—glaucoma	0.0013	0.00277	CcSEcCtD
Conivaptan—Constipation—Apraclonidine—glaucoma	0.0013	0.00276	CcSEcCtD
Conivaptan—Pain—Apraclonidine—glaucoma	0.0013	0.00276	CcSEcCtD
Conivaptan—Hyperglycaemia—Betaxolol—glaucoma	0.0013	0.00276	CcSEcCtD
Conivaptan—Infection—Brimonidine—glaucoma	0.0013	0.00275	CcSEcCtD
Conivaptan—Hypertension—Brinzolamide—glaucoma	0.0013	0.00275	CcSEcCtD
Conivaptan—Pneumonia—Betaxolol—glaucoma	0.00129	0.00274	CcSEcCtD
Conivaptan—Nausea—Carteolol—glaucoma	0.00129	0.00274	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00128	0.00273	CcSEcCtD
Conivaptan—Headache—Levobunolol—glaucoma	0.00128	0.00273	CcSEcCtD
Conivaptan—Infestation—Betaxolol—glaucoma	0.00128	0.00273	CcSEcCtD
Conivaptan—Infestation NOS—Betaxolol—glaucoma	0.00128	0.00273	CcSEcCtD
Conivaptan—Nervous system disorder—Brimonidine—glaucoma	0.00128	0.00272	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00128	0.0225	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00127	0.0027	CcSEcCtD
Conivaptan—Dry mouth—Dorzolamide—glaucoma	0.00127	0.0027	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00127	0.00269	CcSEcCtD
Conivaptan—Skin disorder—Brimonidine—glaucoma	0.00127	0.00269	CcSEcCtD
Conivaptan—Nausea—Diclofenamide—glaucoma	0.00127	0.00269	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00127	0.0224	CbGpPWpGaD
Conivaptan—Dry mouth—Travoprost—glaucoma	0.00127	0.00269	CcSEcCtD
Conivaptan—Pain—Bimatoprost—glaucoma	0.00126	0.00268	CcSEcCtD
Conivaptan—Confusional state—Dorzolamide—glaucoma	0.00126	0.00267	CcSEcCtD
Conivaptan—Feeling abnormal—Apraclonidine—glaucoma	0.00125	0.00266	CcSEcCtD
Conivaptan—Dry mouth—Brinzolamide—glaucoma	0.00125	0.00265	CcSEcCtD
Conivaptan—Vomiting—Methazolamide—glaucoma	0.00125	0.00265	CcSEcCtD
Conivaptan—Hypertension—Pilocarpine—glaucoma	0.00124	0.00264	CcSEcCtD
Conivaptan—Nausea—Carbachol—glaucoma	0.00124	0.00263	CcSEcCtD
Conivaptan—Infection—Travoprost—glaucoma	0.00123	0.00262	CcSEcCtD
Conivaptan—Headache—Methazolamide—glaucoma	0.00123	0.00261	CcSEcCtD
Conivaptan—Cardiac disorder—Clonidine—glaucoma	0.00123	0.00261	CcSEcCtD
Conivaptan—Hypotension—Brimonidine—glaucoma	0.00122	0.00259	CcSEcCtD
Conivaptan—Nausea—Levobunolol—glaucoma	0.00122	0.00259	CcSEcCtD
Conivaptan—Infection—Brinzolamide—glaucoma	0.00122	0.00258	CcSEcCtD
Conivaptan—Nervous system disorder—Travoprost—glaucoma	0.00122	0.00258	CcSEcCtD
Conivaptan—Skin disorder—Travoprost—glaucoma	0.0012	0.00256	CcSEcCtD
Conivaptan—Nervous system disorder—Brinzolamide—glaucoma	0.0012	0.00255	CcSEcCtD
Conivaptan—Angiopathy—Clonidine—glaucoma	0.0012	0.00255	CcSEcCtD
Conivaptan—Mediastinal disorder—Clonidine—glaucoma	0.00119	0.00253	CcSEcCtD
Conivaptan—Headache—Latanoprost—glaucoma	0.00119	0.00253	CcSEcCtD
Conivaptan—Skin disorder—Brinzolamide—glaucoma	0.00119	0.00253	CcSEcCtD
Conivaptan—Confusional state—Pilocarpine—glaucoma	0.00119	0.00252	CcSEcCtD
Conivaptan—Insomnia—Brimonidine—glaucoma	0.00118	0.00251	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00117	0.00249	CcSEcCtD
Conivaptan—Infection—Pilocarpine—glaucoma	0.00117	0.00248	CcSEcCtD
Conivaptan—Nausea—Methazolamide—glaucoma	0.00117	0.00248	CcSEcCtD
Conivaptan—Hypotension—Dorzolamide—glaucoma	0.00116	0.00247	CcSEcCtD
Conivaptan—Mental disorder—Clonidine—glaucoma	0.00116	0.00246	CcSEcCtD
Conivaptan—Hypotension—Travoprost—glaucoma	0.00116	0.00246	CcSEcCtD
Conivaptan—Erythema—Clonidine—glaucoma	0.00115	0.00245	CcSEcCtD
Conivaptan—Hypotension—Brinzolamide—glaucoma	0.00114	0.00243	CcSEcCtD
Conivaptan—Insomnia—Dorzolamide—glaucoma	0.00113	0.00239	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Brimonidine—glaucoma	0.00113	0.00239	CcSEcCtD
Conivaptan—Feeling abnormal—Acetazolamide—glaucoma	0.00112	0.00238	CcSEcCtD
Conivaptan—Pain—Brimonidine—glaucoma	0.00112	0.00237	CcSEcCtD
Conivaptan—Insomnia—Brinzolamide—glaucoma	0.00111	0.00235	CcSEcCtD
Conivaptan—Hypotension—Pilocarpine—glaucoma	0.0011	0.00234	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—OPN4—glaucoma	0.00108	0.019	CbGpPWpGaD
Conivaptan—Pruritus—Apraclonidine—glaucoma	0.00107	0.00228	CcSEcCtD
Conivaptan—Body temperature increased—Acetazolamide—glaucoma	0.00107	0.00228	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—OPN4—glaucoma	0.00107	0.0189	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Travoprost—glaucoma	0.00107	0.00227	CcSEcCtD
Conivaptan—Cardiac disorder—Betaxolol—glaucoma	0.00107	0.00227	CcSEcCtD
Conivaptan—Pain—Dorzolamide—glaucoma	0.00107	0.00226	CcSEcCtD
Conivaptan—Insomnia—Pilocarpine—glaucoma	0.00106	0.00226	CcSEcCtD
Conivaptan—Pain—Travoprost—glaucoma	0.00106	0.00225	CcSEcCtD
Conivaptan—Constipation—Travoprost—glaucoma	0.00106	0.00225	CcSEcCtD
Conivaptan—Hyperglycaemia—Timolol—glaucoma	0.00106	0.00225	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00106	0.00225	CcSEcCtD
Conivaptan—Pain—Brinzolamide—glaucoma	0.00105	0.00222	CcSEcCtD
Conivaptan—Angiopathy—Betaxolol—glaucoma	0.00104	0.00222	CcSEcCtD
Conivaptan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00104	0.0184	CbGpPWpGaD
Conivaptan—Pruritus—Bimatoprost—glaucoma	0.00104	0.00221	CcSEcCtD
Conivaptan—Diarrhoea—Apraclonidine—glaucoma	0.00104	0.00221	CcSEcCtD
Conivaptan—Mediastinal disorder—Betaxolol—glaucoma	0.00104	0.00221	CcSEcCtD
Conivaptan—Feeling abnormal—Dorzolamide—glaucoma	0.00103	0.00218	CcSEcCtD
Conivaptan—Feeling abnormal—Travoprost—glaucoma	0.00102	0.00217	CcSEcCtD
Conivaptan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00102	0.018	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00102	0.00216	CcSEcCtD
Conivaptan—Feeling abnormal—Brinzolamide—glaucoma	0.00101	0.00214	CcSEcCtD
Conivaptan—Mental disorder—Betaxolol—glaucoma	0.00101	0.00214	CcSEcCtD
Conivaptan—Constipation—Pilocarpine—glaucoma	0.00101	0.00214	CcSEcCtD
Conivaptan—Pain—Pilocarpine—glaucoma	0.00101	0.00214	CcSEcCtD
Conivaptan—Erythema—Betaxolol—glaucoma	0.001	0.00213	CcSEcCtD
Conivaptan—Malnutrition—Betaxolol—glaucoma	0.001	0.00213	CcSEcCtD
Conivaptan—Body temperature increased—Dorzolamide—glaucoma	0.000985	0.00209	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000974	0.00207	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—PTGFR—glaucoma	0.000971	0.0171	CbGpPWpGaD
Conivaptan—Feeling abnormal—Pilocarpine—glaucoma	0.00097	0.00206	CcSEcCtD
Conivaptan—Vomiting—Apraclonidine—glaucoma	0.000966	0.00205	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—PTGFR—glaucoma	0.000964	0.017	CbGpPWpGaD
Conivaptan—Dry mouth—Clonidine—glaucoma	0.000959	0.00204	CcSEcCtD
Conivaptan—Headache—Apraclonidine—glaucoma	0.000952	0.00202	CcSEcCtD
Conivaptan—Confusional state—Clonidine—glaucoma	0.000948	0.00201	CcSEcCtD
Conivaptan—Infection—Clonidine—glaucoma	0.000934	0.00198	CcSEcCtD
Conivaptan—Body temperature increased—Pilocarpine—glaucoma	0.00093	0.00198	CcSEcCtD
Conivaptan—Diarrhoea—Acetazolamide—glaucoma	0.00093	0.00198	CcSEcCtD
Conivaptan—Oedema peripheral—Timolol—glaucoma	0.000927	0.00197	CcSEcCtD
Conivaptan—Anaemia—Betaxolol—glaucoma	0.000927	0.00197	CcSEcCtD
Conivaptan—Pruritus—Brimonidine—glaucoma	0.000923	0.00196	CcSEcCtD
Conivaptan—Headache—Bimatoprost—glaucoma	0.000923	0.00196	CcSEcCtD
Conivaptan—Nervous system disorder—Clonidine—glaucoma	0.000922	0.00196	CcSEcCtD
Conivaptan—Skin disorder—Clonidine—glaucoma	0.000913	0.00194	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000906	0.016	CbGpPWpGaD
Conivaptan—Nausea—Apraclonidine—glaucoma	0.000902	0.00192	CcSEcCtD
Conivaptan—Pruritus—Dorzolamide—glaucoma	0.000881	0.00187	CcSEcCtD
Conivaptan—Hypotension—Clonidine—glaucoma	0.000878	0.00187	CcSEcCtD
Conivaptan—Pruritus—Travoprost—glaucoma	0.000877	0.00186	CcSEcCtD
Conivaptan—Nausea—Bimatoprost—glaucoma	0.000875	0.00186	CcSEcCtD
Conivaptan—Cardiac disorder—Timolol—glaucoma	0.000873	0.00186	CcSEcCtD
Conivaptan—Pruritus—Brinzolamide—glaucoma	0.000866	0.00184	CcSEcCtD
Conivaptan—Vomiting—Acetazolamide—glaucoma	0.000864	0.00184	CcSEcCtD
Conivaptan—Angiopathy—Timolol—glaucoma	0.000854	0.00181	CcSEcCtD
Conivaptan—Diarrhoea—Dorzolamide—glaucoma	0.000852	0.00181	CcSEcCtD
Conivaptan—Headache—Acetazolamide—glaucoma	0.000851	0.00181	CcSEcCtD
Conivaptan—Insomnia—Clonidine—glaucoma	0.00085	0.00181	CcSEcCtD
Conivaptan—Diarrhoea—Travoprost—glaucoma	0.000848	0.0018	CcSEcCtD
Conivaptan—Mediastinal disorder—Timolol—glaucoma	0.000848	0.0018	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000848	0.0018	CcSEcCtD
Conivaptan—Diarrhoea—Brinzolamide—glaucoma	0.000838	0.00178	CcSEcCtD
Conivaptan—Dry mouth—Betaxolol—glaucoma	0.000835	0.00177	CcSEcCtD
Conivaptan—Pruritus—Pilocarpine—glaucoma	0.000833	0.00177	CcSEcCtD
Conivaptan—Confusional state—Betaxolol—glaucoma	0.000825	0.00175	CcSEcCtD
Conivaptan—Mental disorder—Timolol—glaucoma	0.000824	0.00175	CcSEcCtD
Conivaptan—Erythema—Timolol—glaucoma	0.000819	0.00174	CcSEcCtD
Conivaptan—Malnutrition—Timolol—glaucoma	0.000819	0.00174	CcSEcCtD
Conivaptan—Headache—Brimonidine—glaucoma	0.000817	0.00174	CcSEcCtD
Conivaptan—Infection—Betaxolol—glaucoma	0.000813	0.00173	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000811	0.00172	CcSEcCtD
Conivaptan—Nausea—Acetazolamide—glaucoma	0.000807	0.00171	CcSEcCtD
Conivaptan—Diarrhoea—Pilocarpine—glaucoma	0.000805	0.00171	CcSEcCtD
Conivaptan—Constipation—Clonidine—glaucoma	0.000804	0.00171	CcSEcCtD
Conivaptan—Pain—Clonidine—glaucoma	0.000804	0.00171	CcSEcCtD
Conivaptan—Nervous system disorder—Betaxolol—glaucoma	0.000802	0.0017	CcSEcCtD
Conivaptan—Skin disorder—Betaxolol—glaucoma	0.000795	0.00169	CcSEcCtD
Conivaptan—Vomiting—Dorzolamide—glaucoma	0.000792	0.00168	CcSEcCtD
Conivaptan—Headache—Dorzolamide—glaucoma	0.00078	0.00166	CcSEcCtD
Conivaptan—Vomiting—Brinzolamide—glaucoma	0.000779	0.00165	CcSEcCtD
Conivaptan—Headache—Travoprost—glaucoma	0.000777	0.00165	CcSEcCtD
Conivaptan—Nausea—Brimonidine—glaucoma	0.000775	0.00165	CcSEcCtD
Conivaptan—Feeling abnormal—Clonidine—glaucoma	0.000774	0.00165	CcSEcCtD
Conivaptan—Headache—Brinzolamide—glaucoma	0.000767	0.00163	CcSEcCtD
Conivaptan—Hypotension—Betaxolol—glaucoma	0.000765	0.00162	CcSEcCtD
Conivaptan—Vomiting—Pilocarpine—glaucoma	0.000748	0.00159	CcSEcCtD
Conivaptan—Body temperature increased—Clonidine—glaucoma	0.000743	0.00158	CcSEcCtD
Conivaptan—Insomnia—Betaxolol—glaucoma	0.00074	0.00157	CcSEcCtD
Conivaptan—Nausea—Dorzolamide—glaucoma	0.00074	0.00157	CcSEcCtD
Conivaptan—Headache—Pilocarpine—glaucoma	0.000737	0.00157	CcSEcCtD
Conivaptan—Nausea—Travoprost—glaucoma	0.000737	0.00156	CcSEcCtD
Conivaptan—Nausea—Brinzolamide—glaucoma	0.000727	0.00155	CcSEcCtD
Conivaptan—Hypertension—Timolol—glaucoma	0.000707	0.0015	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000706	0.0015	CcSEcCtD
Conivaptan—Pain—Betaxolol—glaucoma	0.0007	0.00149	CcSEcCtD
Conivaptan—Constipation—Betaxolol—glaucoma	0.0007	0.00149	CcSEcCtD
Conivaptan—Nausea—Pilocarpine—glaucoma	0.000699	0.00149	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000692	0.00147	CcSEcCtD
Conivaptan—Dry mouth—Timolol—glaucoma	0.000682	0.00145	CcSEcCtD
Conivaptan—Feeling abnormal—Betaxolol—glaucoma	0.000674	0.00143	CcSEcCtD
Conivaptan—Confusional state—Timolol—glaucoma	0.000674	0.00143	CcSEcCtD
Conivaptan—Pruritus—Clonidine—glaucoma	0.000665	0.00141	CcSEcCtD
Conivaptan—Infection—Timolol—glaucoma	0.000664	0.00141	CcSEcCtD
Conivaptan—Nervous system disorder—Timolol—glaucoma	0.000655	0.00139	CcSEcCtD
Conivaptan—Skin disorder—Timolol—glaucoma	0.000649	0.00138	CcSEcCtD
Conivaptan—Body temperature increased—Betaxolol—glaucoma	0.000647	0.00137	CcSEcCtD
Conivaptan—Diarrhoea—Clonidine—glaucoma	0.000643	0.00137	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—EDN1—glaucoma	0.00064	0.0113	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—EDN1—glaucoma	0.000632	0.0112	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.000627	0.0111	CbGpPWpGaD
Conivaptan—Hypotension—Timolol—glaucoma	0.000625	0.00133	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—OPN4—glaucoma	0.000609	0.0108	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—OPN4—glaucoma	0.000605	0.0107	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000605	0.0107	CbGpPWpGaD
Conivaptan—Insomnia—Timolol—glaucoma	0.000605	0.00128	CcSEcCtD
Conivaptan—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.0006	0.0106	CbGpPWpGaD
Conivaptan—Vomiting—Clonidine—glaucoma	0.000598	0.00127	CcSEcCtD
Conivaptan—Headache—Clonidine—glaucoma	0.000589	0.00125	CcSEcCtD
Conivaptan—Pruritus—Betaxolol—glaucoma	0.000579	0.00123	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Timolol—glaucoma	0.000577	0.00123	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000572	0.0101	CbGpPWpGaD
Conivaptan—Pain—Timolol—glaucoma	0.000572	0.00121	CcSEcCtD
Conivaptan—Diarrhoea—Betaxolol—glaucoma	0.00056	0.00119	CcSEcCtD
Conivaptan—Nausea—Clonidine—glaucoma	0.000558	0.00119	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—OPN4—glaucoma	0.000553	0.00977	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—C3—glaucoma	0.000552	0.00975	CbGpPWpGaD
Conivaptan—Feeling abnormal—Timolol—glaucoma	0.000551	0.00117	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—OPN4—glaucoma	0.000549	0.0097	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000549	0.00969	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—C3—glaucoma	0.000548	0.00968	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PTGFR—glaucoma	0.000545	0.00962	CbGpPWpGaD
Conivaptan—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.00053	0.00936	CbGpPWpGaD
Conivaptan—Body temperature increased—Timolol—glaucoma	0.000528	0.00112	CcSEcCtD
Conivaptan—Vomiting—Betaxolol—glaucoma	0.00052	0.00111	CcSEcCtD
Conivaptan—Headache—Betaxolol—glaucoma	0.000513	0.00109	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—PTGFR—glaucoma	0.000498	0.0088	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTGFR—glaucoma	0.000495	0.00874	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—SMO—glaucoma	0.00049	0.00865	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—SMO—glaucoma	0.000486	0.00858	CbGpPWpGaD
Conivaptan—Nausea—Betaxolol—glaucoma	0.000486	0.00103	CcSEcCtD
Conivaptan—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00048	0.00847	CbGpPWpGaD
Conivaptan—Pruritus—Timolol—glaucoma	0.000473	0.001	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—LRP12—glaucoma	0.000472	0.00833	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LRP12—glaucoma	0.000468	0.00827	CbGpPWpGaD
Conivaptan—Diarrhoea—Timolol—glaucoma	0.000457	0.000972	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000443	0.00781	CbGpPWpGaD
Conivaptan—Vomiting—Timolol—glaucoma	0.000425	0.000903	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000424	0.00749	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000421	0.00743	CbGpPWpGaD
Conivaptan—Headache—Timolol—glaucoma	0.000419	0.00089	CcSEcCtD
Conivaptan—Nausea—Timolol—glaucoma	0.000397	0.000844	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00037	0.00654	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000368	0.00649	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000361	0.00637	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPN4—glaucoma	0.000327	0.00577	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPN4—glaucoma	0.000325	0.00573	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—EDN1—glaucoma	0.000323	0.0057	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—EDN1—glaucoma	0.00032	0.00566	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HEYL—glaucoma	0.000304	0.00537	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HEYL—glaucoma	0.000302	0.00533	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTGFR—glaucoma	0.000294	0.0052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTGFR—glaucoma	0.000292	0.00516	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000283	0.005	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—C3—glaucoma	0.000282	0.00498	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—C3—glaucoma	0.00028	0.00494	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—SMO—glaucoma	0.000251	0.00444	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SMO—glaucoma	0.000249	0.00441	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RPTOR—glaucoma	0.00023	0.00407	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000229	0.00404	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RPTOR—glaucoma	0.000229	0.00404	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000226	0.00399	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCK2—glaucoma	0.000223	0.00394	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCK2—glaucoma	0.000221	0.00391	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HDAC9—glaucoma	0.00019	0.00335	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HDAC9—glaucoma	0.000188	0.00333	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000186	0.00328	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—EDN1—glaucoma	0.000182	0.00322	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—EDN1—glaucoma	0.000181	0.0032	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EDN1—glaucoma	0.000166	0.00293	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDN1—glaucoma	0.000164	0.0029	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—C3—glaucoma	0.000159	0.00281	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—C3—glaucoma	0.000158	0.00279	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMO—glaucoma	0.000148	0.00262	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMO—glaucoma	0.000147	0.0026	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—C3—glaucoma	0.000145	0.00256	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—C3—glaucoma	0.000144	0.00254	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK2—glaucoma	0.000136	0.0024	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK2—glaucoma	0.000135	0.00238	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000124	0.00219	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGFR—glaucoma	0.000116	0.00206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGFR—glaucoma	0.000116	0.00204	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK1—glaucoma	0.000111	0.00195	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK1—glaucoma	0.00011	0.00194	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN2B—glaucoma	0.000102	0.0018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN2B—glaucoma	0.000101	0.00179	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.86e-05	0.00174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—glaucoma	9.79e-05	0.00173	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.72e-05	0.00172	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—glaucoma	9.72e-05	0.00172	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGF—glaucoma	8.99e-05	0.00159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGF—glaucoma	8.93e-05	0.00158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NARFL—glaucoma	8.67e-05	0.00153	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA5A—glaucoma	8.67e-05	0.00153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C3—glaucoma	8.55e-05	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C3—glaucoma	8.49e-05	0.0015	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—glaucoma	7.96e-05	0.00141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—glaucoma	7.9e-05	0.0014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—glaucoma	7.89e-05	0.00139	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.88e-05	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—glaucoma	7.83e-05	0.00138	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.77e-05	0.00137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FN1—glaucoma	7.51e-05	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FN1—glaucoma	7.45e-05	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BAD—glaucoma	7.42e-05	0.00131	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BAD—glaucoma	7.36e-05	0.0013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—glaucoma	5.96e-05	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—glaucoma	5.92e-05	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1B—glaucoma	5.17e-05	0.000912	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1B—glaucoma	5.13e-05	0.000906	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—glaucoma	4.78e-05	0.000845	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—glaucoma	4.75e-05	0.000839	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—glaucoma	4.3e-05	0.000759	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—glaucoma	4.26e-05	0.000753	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA1—glaucoma	4.24e-05	0.000748	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CTSA—glaucoma	4.1e-05	0.000724	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA2—glaucoma	3.87e-05	0.000684	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—glaucoma	3.25e-05	0.000573	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—glaucoma	3.22e-05	0.000569	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TXN—glaucoma	2.73e-05	0.000482	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—glaucoma	2.12e-05	0.000374	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—glaucoma	1.69e-05	0.000298	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1B1—glaucoma	1.69e-05	0.000298	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—glaucoma	1.35e-05	0.000238	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—glaucoma	1.19e-05	0.00021	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—glaucoma	1.11e-05	0.000196	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—glaucoma	1.1e-05	0.000194	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—glaucoma	8.31e-06	0.000147	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—glaucoma	7.6e-06	0.000134	CbGpPWpGaD
